Ideas and updates for teams leading change, strengthening learning, and building commercial excellence.
Many biopharma organizations will enter 2027 without knowing whether this year's changes took hold. Wendy Heckelman, Ph.D. explains how to separate adoption, proficiency, and...
Read the article
Most pharma organizations now have AI somewhere in their commercial workflow, yet far fewer can say what it has produced. Wendy Heckelman, Ph.D. explains...
Read the article
Roughly eight in ten US physicians now practice as employees of health systems or other corporate entities. The prescriber your rep meets on Tuesday...
Read the article
Fall has arrived and during September the pace of business changes. Summer is over, the team is back out in the field, and the...
Read the article
By Wendy Heckelman, Ph.D., Tianna Tye, MAIOP Look at nearly any 2027 biopharma commercial or medical budget and you will find a line for...
Read the article
Every summer, biopharma commercial teams pause for mid-year business reviews. Most of that time goes to performance: what the numbers say, where the gaps...
Read the article
Traditional pre-call planning is no longer enough in today’s complex healthcare ecosystem. High-performing biopharma reps build ecosystem acumen by reading account-level changes in ownership,...
Read the article
LTEN 2026 underscored that learning teams are increasingly expected to connect capability building to measurable business outcomes, not just attendance or activity. WLH’s top...
Read the article
Cross-functional misalignment in biopharma is often treated as a people problem, but the root cause is usually structural. When Medical Affairs, Commercial, and Market...
Read the article
As healthcare decision-making becomes more complex, field teams need more than traditional pre-call planning. Strong ecosystem acumen helps reps identify account-level shifts in ownership,...
Read the article
For decades, the biopharma sales rep playbook has had a clear sequence: Build a territory plan, segment and prioritize HCP, and then pre-call plan...
Read the article
Every biopharma transformation has a moment that looks like progress. A strategy is approved, the town hall occurs, and the announcement goes out. Six...
Read the article